Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Mesothelioma × Axitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Carcinoma, Renal Cell 24 Kidney Neoplasms 10 Neoplasms 9 Carcinoma 6 Colorectal Neoplasms 5 Carcinoma, Hepatocellular 5 Carcinoma, Non-Small-Cell Lung 4 Recurrence 3 Neoplasm Metastasis 3 Melanoma 3 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Lung Neoplasms 2 Kidney Diseases 2 Glioblastoma 2 Carcinoma, Adenoid Cystic 2 Breast Neoplasms 2 Advanced Solid Tumors 2 cT2a N0NxM0 Renal Tumor 1 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Solitary Fibrous Tumors 1 Solid Tumors 1 Solid Malignancies 1 Skin Neoplasms 1 Sarcoma, Alveolar Soft Part 1 Salivary Gland Neoplasms 1 Refractory or Recurrent Solid Tumors, Excluding CNS Tumors 1 Prostatic Neoplasms 1

Interventions

Pemetrexed 23 Cisplatin 19 Nivolumab 8 Gemcitabine 7 Ipilimumab 6 Carboplatin 6 pembrolizumab 4 Bevacizumab 4 tazemetostat 3 durvalumab 3 Fluorouracil 3 Drug Therapy 3 spartalizumab 2 olaparib 2 niraparib 2 budigalimab 2 belinostat 2 anetumab ravtansine 2 amatuximab 2 Vinorelbine 2 Radiotherapy, Intensity-Modulated 2 Paclitaxel 2 PM 01183 2 Oxaliplatin 2 Imatinib Mesylate 2 Everolimus 2 Erlotinib Hydrochloride 2 Doxorubicin 2 Cyclophosphamide 2 venetoclax 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01211275 2017-02-28

N08CPA

The Netherlands Cancer Institute

Phase 1/2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡